Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 
This article has been cited by
1Characteristics ofBCR-ABLkinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance
Nikhil Patkar,Kiran Ghodke,Swapnali Joshi,Shruti Chaudhary,Russel Mascerhenas,Sona Dusseja,Shashikant Mahadik,Sheetal Gaware,Prashant Tembhare,Sumeet Gujral,Sharayu Kabre,Pratibha Kadam-Amare,Hasmukh Jain,Uma Dangi,Bhausaheb Bagal,Navin Khattry,Manju Sengar,Brijesh Arora,Gaurav Narula,Shripad Banavali,Hari Menon,Papagudi Ganesan Subramanian
Leukemia & Lymphoma.2016;57(11)2653
[DOI]
2Chronic Myeloid Leukemia in India
Prasanth Ganesan,Lalit Kumar
Journal of Global Oncology.2017;3(1)64
[DOI]
3Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era
Prasanth Ganesan,Trivadi S. Ganesan,Venkatraman Radhakrishnan,Tenali Gnana Sagar,Krishnarathinam Kannan,Manikandan Dhanushkodi,Jayachandran Perumal Kalayarasi,Nikita Mehra
Indian Journal of Hematology and Blood Transfusion.2019;35(1)37
[DOI]
4Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving Imatinib
Radhika Unnikrishnan,Surendran Veeraiah,Samson Mani,Rejiv Rajendranath,Swaminathan Rajaraman,Grace Sahaya Vidhubala Elangovan,Venkatraman Radhakrishnan,Trivadi S. Ganesan,Tenali G. Sagar,Prasanth Ganesan
Clinical Lymphoma Myeloma and Leukemia.2016;16(6)366
[DOI]
  Feedback 
  Subscribe